abstract |
The present invention provides methods and product for inhibiting mammalian cell proliferation. Compounds that are anti-mycotics and that inhibit the Ca++-activated potassium channel of erythrocytes have been modified for use in the present invention by removing the imidazole group. Such modified compounds typically have at least aromatic groups separated from one another by not more than five atoms, and more typically not more than three atoms. At least one of the aromatic groups is substituted with a chlorine or another functionality with an overall net negative charge. The compounds can be used in connection with, inter alia, treatments for cancer, treatments for arteriosclerotic conditions, treatments for angiogenic conditions and other cell proliferative disorders. |